Northern Trust’s Tenax Therapeutics TENX Stock Holding History

Northern Trust’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$193K	Buy	+12,049	New	+$163K	﹤0.01%	3960
2023 Q1	–	Sell	-22	Closed	-$3.86K	–	4626
2022 Q4	$3.86K	Hold	22	–	–	﹤0.01%	4634
2022 Q3	$6K	Hold	22	–	–	﹤0.01%	4671
2022 Q2	$10K	Hold	22	–	–	﹤0.01%	4696
2022 Q1	$28K	Hold	22	–	–	﹤0.01%	4635
2021 Q4	$36K	Hold	22	–	–	﹤0.01%	4641
2021 Q3	$61K	Hold	22	–	–	﹤0.01%	4499
2021 Q2	$72K	Buy	22 +11	+100%	+$34.9K	﹤0.01%	4425
2021 Q1	$32K	Hold	11	–	–	﹤0.01%	4415
2020 Q4	$32K	Hold	11	–	–	﹤0.01%	4279
2020 Q3	$26K	Buy	11 +4	+57%	+$8.54K	﹤0.01%	4181
2020 Q2	$11K	Buy	+7	New	+$10.3K	﹤0.01%	4210
2018 Q1	–	Sell	-2	Closed	-$25K	–	4279
2017 Q4	$25K	Hold	2	–	–	﹤0.01%	4138
2017 Q3	$18K	Hold	2	–	–	﹤0.01%	4165
2017 Q2	$38K	Hold	2	–	–	﹤0.01%	4116
2017 Q1	$29K	Buy	2 +1	+100%	+$36.3K	﹤0.01%	4121
2016 Q4	$61K	Hold	1	–	–	﹤0.01%	3983
2016 Q3	$69K	Hold	1	–	–	﹤0.01%	3956
2016 Q2	$78K	Hold	1	–	–	﹤0.01%	3945
2016 Q1	$61K	Hold	1	–	–	﹤0.01%	3991
2015 Q4	$92K	Hold	1	–	–	﹤0.01%	3954
2015 Q3	$87K	Hold	1	–	–	﹤0.01%	3970
2015 Q2	$91K	Hold	1	–	–	﹤0.01%	3970
2015 Q1	$99K	Hold	1	–	–	﹤0.01%	4040
2014 Q4	$117K	Hold	1	–	–	﹤0.01%	3951
2014 Q3	$140K	Hold	1	–	–	﹤0.01%	3944
2014 Q2	$146K	Buy	+1	New	+$154K	﹤0.01%	3926
2014 Q1	–	Hold	0	–	–	–	4025

Other funds holding TENX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Northern Trust's TENX Position: Q1 2026 in Review

Northern Trust opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 12,049 shares worth $193K. The stake represents ﹤0.01% of the portfolio and ranks #3960 among its holdings. This is a return to the name: Northern Trust previously reported a position in TENX as recently as Q4 2022.

Northern Trust first reported a position in TENX in Q2 2014 and has held it in 27 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

Northern Trust held 12,049 shares of Tenax Therapeutics worth $193K as of Q1 2026.
Tenax Therapeutics was a new Northern Trust position in Q1 2026.
Tenax Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3960 holding.
Northern Trust first reported a position in Tenax Therapeutics in Q2 2014 and has held it in 27 quarters since.
80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.